カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のエファビレンツ市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Efavirenz Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19283）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19283
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のエファビレンツ市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

エファビレンツ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のエファビレンツの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

エファビレンツ市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・エファビレンツ単剤、2剤合剤、3剤合剤

用途別セグメントは次のように区分されます。
・大人、子供

世界のエファビレンツ市場の主要な市場プレーヤーは以下のとおりです。
・Bristol-Myers Squibb、Teva、Mylan、Aurobindo Pharma、Cipla、Macleods Pharmaceuticals、Hetero、Strides Pharma、Gilead Sciences

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エファビレンツ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエファビレンツメーカーの企業概要、2019年～2022年までのエファビレンツの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエファビレンツメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別エファビレンツの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのエファビレンツの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのエファビレンツ市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびエファビレンツの産業チェーンを掲載しています。
・第13、14、15章では、エファビレンツの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- エファビレンツの概要
- 種類別分析（2017年vs2021年vs2028年）：エファビレンツ単剤、2剤合剤、3剤合剤
- 用途別分析（2017年vs2021年vs2028年）：大人、子供
- 世界のエファビレンツ市場規模・予測
- 世界のエファビレンツ生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bristol-Myers Squibb、Teva、Mylan、Aurobindo Pharma、Cipla、Macleods Pharmaceuticals、Hetero、Strides Pharma、Gilead Sciences
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：エファビレンツ単剤、2剤合剤、3剤合剤
・用途別分析2017年-2028年：大人、子供
・エファビレンツの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・エファビレンツのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・エファビレンツのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エファビレンツの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・エファビレンツの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Efavirenz market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Efavirenz market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults accounting for % of the Efavirenz global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Efavirenz segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Efavirenz include Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, and Cipla, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Efavirenz market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Efavirenz
Two-drug combination
Three-drug combination
Market segment by Application can be divided into
Adults
Children
The key market players for global Efavirenz market are listed below:
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Efavirenz product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Efavirenz, with price, sales, revenue and global market share of Efavirenz from 2019 to 2022.
Chapter 3, the Efavirenz competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Efavirenz breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Efavirenz market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Efavirenz.
Chapter 13, 14, and 15, to describe Efavirenz sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Efavirenz Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Efavirenz Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Efavirenz
1.2.3 Two-drug combination
1.2.4 Three-drug combination
1.3 Market Analysis by Application
1.3.1 Overview: Global Efavirenz Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.4 Global Efavirenz Market Size & Forecast
1.4.1 Global Efavirenz Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Efavirenz Sales in Volume (2017-2028)
1.4.3 Global Efavirenz Price (2017-2028)
1.5 Global Efavirenz Production Capacity Analysis
1.5.1 Global Efavirenz Total Production Capacity (2017-2028)
1.5.2 Global Efavirenz Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Efavirenz Market Drivers
1.6.2 Efavirenz Market Restraints
1.6.3 Efavirenz Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Efavirenz Product and Services
2.1.4 Bristol-Myers Squibb Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Efavirenz Product and Services
2.2.4 Teva Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Efavirenz Product and Services
2.3.4 Mylan Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Efavirenz Product and Services
2.4.4 Aurobindo Pharma Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Efavirenz Product and Services
2.5.4 Cipla Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Macleods Pharmaceuticals
2.6.1 Macleods Pharmaceuticals Details
2.6.2 Macleods Pharmaceuticals Major Business
2.6.3 Macleods Pharmaceuticals Efavirenz Product and Services
2.6.4 Macleods Pharmaceuticals Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hetero
2.7.1 Hetero Details
2.7.2 Hetero Major Business
2.7.3 Hetero Efavirenz Product and Services
2.7.4 Hetero Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Strides Pharma
2.8.1 Strides Pharma Details
2.8.2 Strides Pharma Major Business
2.8.3 Strides Pharma Efavirenz Product and Services
2.8.4 Strides Pharma Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business
2.9.3 Gilead Sciences Efavirenz Product and Services
2.9.4 Gilead Sciences Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Efavirenz Breakdown Data by Manufacturer
3.1 Global Efavirenz Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Efavirenz Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Efavirenz
3.4 Market Concentration Rate
3.4.1 Top 3 Efavirenz Manufacturer Market Share in 2021
3.4.2 Top 6 Efavirenz Manufacturer Market Share in 2021
3.5 Global Efavirenz Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Efavirenz Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Efavirenz Market Size by Region
4.1.1 Global Efavirenz Sales in Volume by Region (2017-2028)
4.1.2 Global Efavirenz Revenue by Region (2017-2028)
4.2 North America Efavirenz Revenue (2017-2028)
4.3 Europe Efavirenz Revenue (2017-2028)
4.4 Asia-Pacific Efavirenz Revenue (2017-2028)
4.5 South America Efavirenz Revenue (2017-2028)
4.6 Middle East and Africa Efavirenz Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Efavirenz Sales in Volume by Type (2017-2028)
5.2 Global Efavirenz Revenue by Type (2017-2028)
5.3 Global Efavirenz Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Efavirenz Sales in Volume by Application (2017-2028)
6.2 Global Efavirenz Revenue by Application (2017-2028)
6.3 Global Efavirenz Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Efavirenz Sales by Type (2017-2028)
7.2 North America Efavirenz Sales by Application (2017-2028)
7.3 North America Efavirenz Market Size by Country
7.3.1 North America Efavirenz Sales in Volume by Country (2017-2028)
7.3.2 North America Efavirenz Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Efavirenz Sales by Type (2017-2028)
8.2 Europe Efavirenz Sales by Application (2017-2028)
8.3 Europe Efavirenz Market Size by Country
8.3.1 Europe Efavirenz Sales in Volume by Country (2017-2028)
8.3.2 Europe Efavirenz Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Efavirenz Sales by Type (2017-2028)
9.2 Asia-Pacific Efavirenz Sales by Application (2017-2028)
9.3 Asia-Pacific Efavirenz Market Size by Region
9.3.1 Asia-Pacific Efavirenz Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Efavirenz Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Efavirenz Sales by Type (2017-2028)
10.2 South America Efavirenz Sales by Application (2017-2028)
10.3 South America Efavirenz Market Size by Country
10.3.1 South America Efavirenz Sales in Volume by Country (2017-2028)
10.3.2 South America Efavirenz Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Efavirenz Sales by Type (2017-2028)
11.2 Middle East & Africa Efavirenz Sales by Application (2017-2028)
11.3 Middle East & Africa Efavirenz Market Size by Country
11.3.1 Middle East & Africa Efavirenz Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Efavirenz Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Efavirenz and Key Manufacturers
12.2 Manufacturing Costs Percentage of Efavirenz
12.3 Efavirenz Production Process
12.4 Efavirenz Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Efavirenz Typical Distributors
13.3 Efavirenz Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Efavirenz Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Efavirenz Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Efavirenz Product and Services
Table 6. Bristol-Myers Squibb Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Efavirenz Product and Services
Table 10. Teva Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Efavirenz Product and Services
Table 14. Mylan Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Major Business
Table 17. Aurobindo Pharma Efavirenz Product and Services
Table 18. Aurobindo Pharma Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Cipla Basic Information, Manufacturing Base and Competitors
Table 20. Cipla Major Business
Table 21. Cipla Efavirenz Product and Services
Table 22. Cipla Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Macleods Pharmaceuticals Major Business
Table 25. Macleods Pharmaceuticals Efavirenz Product and Services
Table 26. Macleods Pharmaceuticals Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hetero Basic Information, Manufacturing Base and Competitors
Table 28. Hetero Major Business
Table 29. Hetero Efavirenz Product and Services
Table 30. Hetero Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Strides Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Strides Pharma Major Business
Table 33. Strides Pharma Efavirenz Product and Services
Table 34. Strides Pharma Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 36. Gilead Sciences Major Business
Table 37. Gilead Sciences Efavirenz Product and Services
Table 38. Gilead Sciences Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Efavirenz Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Efavirenz Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Efavirenz, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Efavirenz Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Efavirenz Production Site of Key Manufacturer
Table 44. Efavirenz New Entrant and Capacity Expansion Plans
Table 45. Efavirenz Mergers & Acquisitions in the Past Five Years
Table 46. Global Efavirenz Sales by Region (2017-2022) & (K Units)
Table 47. Global Efavirenz Sales by Region (2023-2028) & (K Units)
Table 48. Global Efavirenz Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Efavirenz Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Efavirenz Sales by Type (2017-2022) & (K Units)
Table 51. Global Efavirenz Sales by Type (2023-2028) & (K Units)
Table 52. Global Efavirenz Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Efavirenz Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Efavirenz Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Efavirenz Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Efavirenz Sales by Application (2017-2022) & (K Units)
Table 57. Global Efavirenz Sales by Application (2023-2028) & (K Units)
Table 58. Global Efavirenz Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Efavirenz Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Efavirenz Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Efavirenz Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Efavirenz Sales by Country (2017-2022) & (K Units)
Table 63. North America Efavirenz Sales by Country (2023-2028) & (K Units)
Table 64. North America Efavirenz Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Efavirenz Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Efavirenz Sales by Type (2017-2022) & (K Units)
Table 67. North America Efavirenz Sales by Type (2023-2028) & (K Units)
Table 68. North America Efavirenz Sales by Application (2017-2022) & (K Units)
Table 69. North America Efavirenz Sales by Application (2023-2028) & (K Units)
Table 70. Europe Efavirenz Sales by Country (2017-2022) & (K Units)
Table 71. Europe Efavirenz Sales by Country (2023-2028) & (K Units)
Table 72. Europe Efavirenz Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Efavirenz Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Efavirenz Sales by Type (2017-2022) & (K Units)
Table 75. Europe Efavirenz Sales by Type (2023-2028) & (K Units)
Table 76. Europe Efavirenz Sales by Application (2017-2022) & (K Units)
Table 77. Europe Efavirenz Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Efavirenz Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Efavirenz Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Efavirenz Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Efavirenz Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Efavirenz Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Efavirenz Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Efavirenz Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Efavirenz Sales by Application (2023-2028) & (K Units)
Table 86. South America Efavirenz Sales by Country (2017-2022) & (K Units)
Table 87. South America Efavirenz Sales by Country (2023-2028) & (K Units)
Table 88. South America Efavirenz Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Efavirenz Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Efavirenz Sales by Type (2017-2022) & (K Units)
Table 91. South America Efavirenz Sales by Type (2023-2028) & (K Units)
Table 92. South America Efavirenz Sales by Application (2017-2022) & (K Units)
Table 93. South America Efavirenz Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Efavirenz Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Efavirenz Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Efavirenz Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Efavirenz Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Efavirenz Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Efavirenz Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Efavirenz Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Efavirenz Sales by Application (2023-2028) & (K Units)
Table 102. Efavirenz Raw Material
Table 103. Key Manufacturers of Efavirenz Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Efavirenz Typical Distributors
Table 107. Efavirenz Typical Customers
List of Figures
Figure 1. Efavirenz Picture
Figure 2. Global Efavirenz Revenue Market Share by Type in 2021
Figure 3. Single Efavirenz
Figure 4. Two-drug combination
Figure 5. Three-drug combination
Figure 6. Global Efavirenz Revenue Market Share by Application in 2021
Figure 7. Adults
Figure 8. Children
Figure 9. Global Efavirenz Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Efavirenz Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Efavirenz Sales (2017-2028) & (K Units)
Figure 12. Global Efavirenz Price (2017-2028) & (USD/Unit)
Figure 13. Global Efavirenz Production Capacity (2017-2028) & (K Units)
Figure 14. Global Efavirenz Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Efavirenz Market Drivers
Figure 16. Efavirenz Market Restraints
Figure 17. Efavirenz Market Trends
Figure 18. Global Efavirenz Sales Market Share by Manufacturer in 2021
Figure 19. Global Efavirenz Revenue Market Share by Manufacturer in 2021
Figure 20. Efavirenz Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Efavirenz Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Efavirenz Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Efavirenz Sales Market Share by Region (2017-2028)
Figure 24. Global Efavirenz Revenue Market Share by Region (2017-2028)
Figure 25. North America Efavirenz Revenue (2017-2028) & (USD Million)
Figure 26. Europe Efavirenz Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Efavirenz Revenue (2017-2028) & (USD Million)
Figure 28. South America Efavirenz Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Efavirenz Revenue (2017-2028) & (USD Million)
Figure 30. Global Efavirenz Sales Market Share by Type (2017-2028)
Figure 31. Global Efavirenz Revenue Market Share by Type (2017-2028)
Figure 32. Global Efavirenz Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Efavirenz Sales Market Share by Application (2017-2028)
Figure 34. Global Efavirenz Revenue Market Share by Application (2017-2028)
Figure 35. Global Efavirenz Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Efavirenz Sales Market Share by Type (2017-2028)
Figure 37. North America Efavirenz Sales Market Share by Application (2017-2028)
Figure 38. North America Efavirenz Sales Market Share by Country (2017-2028)
Figure 39. North America Efavirenz Revenue Market Share by Country (2017-2028)
Figure 40. United States Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Efavirenz Sales Market Share by Type (2017-2028)
Figure 44. Europe Efavirenz Sales Market Share by Application (2017-2028)
Figure 45. Europe Efavirenz Sales Market Share by Country (2017-2028)
Figure 46. Europe Efavirenz Revenue Market Share by Country (2017-2028)
Figure 47. Germany Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Efavirenz Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Efavirenz Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Efavirenz Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Efavirenz Revenue Market Share by Region (2017-2028)
Figure 56. China Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Efavirenz Sales Market Share by Type (2017-2028)
Figure 63. South America Efavirenz Sales Market Share by Application (2017-2028)
Figure 64. South America Efavirenz Sales Market Share by Country (2017-2028)
Figure 65. South America Efavirenz Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Efavirenz Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Efavirenz Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Efavirenz Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Efavirenz Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Efavirenz Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Efavirenz in 2021
Figure 77. Manufacturing Process Analysis of Efavirenz
Figure 78. Efavirenz Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の三次元電気生理ナビゲーションシステム市場2022年：市場規模予測（～2028年）
  • 世界のアンフェタミン薬市場2022年：市場規模予測（～2028年）
  • 世界の金属製冠動脈ステント市場2022年：市場規模予測（～2028年）
  • 世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19283 )"世界のエファビレンツ市場2022年：市場規模予測（～2028年）" (英文：Global Efavirenz Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。